Zilganersen

N/A

Report date: 2026/03/26 17:38:17

Base Information

Drug NameZilganersen
Drug Alias Name2''-O-(2-methoxyethyl)-D-ribose antisense oligonucleotide targeting glial fibrillary acidic protein messenger ribonucleic acidION-373
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionGlial fibrillary acidic protein inhibitors
TargetsGlial fibrillary acidic protein
Therapy Area/IndicationsAlexander Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[8] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesIonis Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAlexander Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A